Summary box Health workers were differentially infected during the 2014 to 2016 Ebola outbreak with an incidence rate of 30 to 44/1000 depending on their job duties, compared to the wider population’s ...

A global consortium led by Adaptvac ApS aims to design and test a new vaccine that could offer broad protection against several filoviruses, including Zaire ebolavirus, Sudan ebolavirus and Marburg ...

Researchers at Wageningen University & Research (WUR) are contributing to the development of a new vaccine designed to provide broad protection ...

Hørsholm, Denmark, 19 June 2025 - ExpreS2ion Biotech Holding AB's affiliate ExpreS2ion Biotechnologies ApS ("ExpreS2ion") today announced that its associated company AdaptVac ApS ("AdaptVac"), of ...